New Zealand markets close in 50 minutes

Cano Health, Inc. (CANO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
0.2556-0.0179 (-6.54%)
At close: 04:00PM EDT
0.2540 -0.00 (-0.63%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 78.08M
Enterprise value 1.28B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.02
Price/book (mrq)0.53
Enterprise value/revenue 0.43
Enterprise value/EBITDA -2.31

Trading information

Stock price history

Beta (5Y monthly) 0.24
52-week change 3-97.10%
S&P500 52-week change 313.87%
52-week high 39.7500
52-week low 30.2200
50-day moving average 30.6065
200-day moving average 31.1395

Share statistics

Avg vol (3-month) 311.46M
Avg vol (10-day) 37.73M
Shares outstanding 5285.48M
Implied shares outstanding 6576.41M
Float 8206.46M
% held by insiders 122.02%
% held by institutions 148.88%
Shares short (14 Sept 2023) 432.8M
Short ratio (14 Sept 2023) 41.88
Short % of float (14 Sept 2023) 414.43%
Short % of shares outstanding (14 Sept 2023) 411.49%
Shares short (prior month 14 Aug 2023) 427.54M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Jun 2023


Profit margin -12.47%
Operating margin (ttm)-10.80%

Management effectiveness

Return on assets (ttm)-10.44%
Return on equity (ttm)-138.39%

Income statement

Revenue (ttm)2.98B
Revenue per share (ttm)12.04
Quarterly revenue growth (yoy)11.20%
Gross profit (ttm)421.69M
EBITDA -223.38M
Net income avi to common (ttm)-371.5M
Diluted EPS (ttm)-1.6000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)27.72M
Total cash per share (mrq)0.1
Total debt (mrq)1.23B
Total debt/equity (mrq)522.35%
Current ratio (mrq)0.49
Book value per share (mrq)0.53

Cash flow statement

Operating cash flow (ttm)-109.12M
Levered free cash flow (ttm)29.14M